CME/CE: HIV Transmission Risk During Antiretroviral Therapy

CME/CE: HIV Transmission Risk During Antiretroviral Therapy
Author Information (click to view)

Andrew Mujugira, MD, PhD

Postdoctoral Fellow
International Clinical Research Center
University of Washington

 

Andrew Mujugira, MD, PhD, has indicated to Physician’s Weekly that he has no financial interests to disclose.

+


Andrew Mujugira, MD, PhD (click to view)

Andrew Mujugira, MD, PhD

Postdoctoral Fellow
International Clinical Research Center
University of Washington

 

Andrew Mujugira, MD, PhD, has indicated to Physician’s Weekly that he has no financial interests to disclose.

The risk for transmitting HIV appears to persist during the first 6 months of antiretroviral therapy (ART), according to a study. For those taking ART for less than 6 months, researchers observed that patients had incomplete viral suppression in blood and genital compartments.
Share on FacebookTweet about this on TwitterShare on LinkedIn

Submit a Comment

Your email address will not be published. Required fields are marked *

19 + seventeen =